These observations were further supported by the identification of a SNP in the GFI1 gene that generates a variant protein (GFI1[36N]), which experimentally accelerated KRas-driven myeloproliferative disorders by inducing epigenetic changes at the HoxA9 locus21. This evidence concerns the gene KRAS and myeloproliferative disorder.